Home   About this service   Get the news  
+32 2 743 34 03

 Belgium  Other Countries
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
Gimv [BE0003699130/GIMB]   
[10/12/2018]

Gimv : Monaghan Mushrooms acquires 100% of Walkro, a leading producer of substrate for the mushroom industry

PRESS RELEASE Venlo NL / Tyholland IE / Antwerp BE, 10 December 2018, 07:30 AM CET Monaghan Mushrooms acquires 100% of Walkro, a leading producer of substrate for the mushroom industry Irish company Monaghan Mushrooms has agreed to acquire all shares of Walkro held by Gimv and Walkro’s management. Walkro www.walkro.eu was founded in Belgium... See more
 
Gimv [BE0003699130/GIMB]   
[22/11/2018]

Gimv : Excellent half-year result reflects enlarged portfolio and further growth at our portfolio companies

Antwerp / 22 November 2018 / 07.00 CET Excellent halfyear result reflects enlarged portfolio and further growth at our portfolio companies Managing Director Koen Dejonckheere, on the past halfyears results: The past six months were marked by further portfolio growth. Despite more than EUR 1.5 billion of exits over the past 5 years, the portfolio has... See more
 
Gimv [BE0003699130/GIMB]   
[16/11/2018]

Gimv : Gimv in exclusive negotiations with Industries & Finances to become majority shareholder of Groupe Claire

Antwerp BE / Paris FR, 16 November 2018, 07:30 CET embargo Gimv in exclusive negotiations with Industries & Finances to become majority shareholder of Groupe Claire Gimv will be acquiring a majority stake in Groupe Claire, alongside its management, in order to support the company’s development in France and abroad, both with its traditional as well as with ... See more
 
Gimv [BE0003699130/GIMB]   
[15/11/2018]

Gimv : Gimv invests in Belgian biotech company Camel-IDS, to support its unique radio-immunotherapy platform

Antwerp BE, 15 November 2018, 7:30 AM CET embargo Gimv invests in Belgian biotech company CamelIDS, to support its unique radioimmunotherapy platform CamelIDS, a Brusselsbased company developing cancertargeted radiopharmaceuticals today announced the completion of a seriesA financing round, whereby the company secured funding of EUR 37 million. Gimv,... See more
 
Gimv [BE0003699130/GIMB]   
[30/10/2018]

Gimv : Gimv enters into exclusivity with Cerea Capital II to become majority shareholder of La Comtoise alongside the company’s Chairman and founder

Gimv enters into exclusivity with Cerea Capital II to become majority shareholder of La Comtoise alongside the company’s Chairman and founder Gimv will acquire a majority interest in La Comtoise, alongside Michel Vanhove and the management team, to support the company in its growth and... See more